Dylan Coronado
Pharmacogenomic testing for SSRIs analyzes CYP2C19 and CYP2D6 genes to predict how your body metabolizes antidepressants. This can prevent severe side effects by matching drug choice and dose to your genetics.
Sep 20 2025
Jun 10 2026
Jun 18 2026
Feb 1 2026
Jan 24 2026